
Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 02, 2024, titled "Press Release for the quarter and nine months ended December 31, 2023".
Filed with NSE ·

Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 02, 2024, titled "Press Release for the quarter and nine months ended December 31, 2023".
6ix hasn’t read this filing yet.
Jagsonpal Pharmaceuticals Ltd. on 6ix
Follow Jagsonpal Pharmaceuticals into a list and get an email when it puts out news.
Follow Jagsonpal Pharmaceuticals